From: Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis
Clinicopathological | Â | PC mRNA | Â | Â |
---|---|---|---|---|
 | n | Median a (IR) | Ζ | P-value |
Age (years) | ||||
 < 55 | 31 | 0.192 [0.059 ~ 0.351] | −1.412 | 0.167 |
 ≥ 55 | 7 | 0.389 [0.149 ~ 2.321] |  |  |
Sexual | ||||
 Male | 12 | 0.354 [0.140 ~ 1.944] | −2.324 | 0.020* |
 Female | 26 | 0.149 [0.029 ~ 0.313] |  |  |
TNM | ||||
 I-II | 14 | 0.137 [0.044 ~ 0.350] | −1.422 | 0.155 |
 III-IV | 24 | 0.304 [0.096 ~ 0.980] |  |  |
Lymph node metastasis | ||||
 with | 24 | 0.310 [0.134 ~ 1.069] | −2.330 | 0.019* |
 without | 14 | 0.102 [0.029 ~ 0.193] |  |  |